Vitamin D Status in Children With Sickle Cell Disease Living in Lyon, France

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-04

Study Completion Date

2022-02-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vitamin D deficiency may be under-diagnosed in sickle cell disease French children. Therefore, the investigator need an epidemiologic study about the prevalence of vitamin D deficiency in this specific population. There are not specific guidelines neither testing nor treatment. The investigator propose to test vitamin D status in all children with sickle cell disease who are consulting their referring haematologist doctor or in the emergency ward.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vitamin D, Bones, Nutritional and Cardiovascular Status

NCT01832623

Vitamin D

COMPLETED NA

Study of Vitamin D in Children With Sickle Cell Disease

NCT01276587

Sickle Cell Disease

COMPLETED PHASE1/PHASE2

Vitamin D3 in Patients With Sickle Cell Disease

NCT03012555

Sickle Cell Disease

COMPLETED

Vitamin D for Sickle-cell Respiratory Complications

NCT01443728

Sickle Cell Disease Vitamin D Deficiency Acute Chest Syndrome +2 more

COMPLETED PHASE2

Daily Vitamin D for Sickle-cell Respiratory Complications

NCT04170348

Sickle Cell Disease Anemia, Sickle Cell Anemia, Hemolytic, Congenital +9 more

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitamin D Deficiency Sickle Cell Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sickle cell disease children from Lyon, France

Sickle cell disease children, followed in IHOPe (Institut d'Hématologie et d'Oncologie Pédiatrique) center, consulting their referring haematologist doctor or in emergency ward, with prescribed blood sample.

25-OH Vitamin D measure

Intervention Type BIOLOGICAL

As a complement to the off-study prescription, the investigator are taking two 1 mL tubes of extra blood to measure vitamin D, calcium, phosphorus, parathyroid hormone (PTH) and creatinine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

25-OH Vitamin D measure

As a complement to the off-study prescription, the investigator are taking two 1 mL tubes of extra blood to measure vitamin D, calcium, phosphorus, parathyroid hormone (PTH) and creatinine.

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children: under 18 years old
* Sickle cell any genetic type homozygous or composite heterozygous
* To receive an assessment independently of the study, during a presentation to the emergency ward and/or a follow-up consultation by the hematologist
* no parental opposition signed by at least one parent/legal representative and no child opposition
* social security beneficiary